Supplementary Figure S1 a

Slides:

Advertisements

Similar presentations

Figure 1 HuR Tis11b HPRT VEGF Time (h) A 462 bp (VEGF 165 ) 332 bp (VEGF 121 ) 354 bp 111 bp 305 bp.

Advertisements

Knight et al – Supplementary Table Supplemental Table 1: Cell line Densitometry AROSSIRT1 ARPE WI MCF10A HCT HCT116.

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Effects of declining sorafenib levels and dose on acquired reversible resistance and toxicity in hepatocellular carcinoma Elizabeth A. Kuczynski, Christina.

Xenograft TDDoxorubicinCisplatinIfosfamide SGDT/C%EfficacySGDT/C%EfficacySGDT/C%Efficacy OHS > CTPX > SBX6, >

(z=7) (z=7) (z=7) (z=7) MSMS/MS Ba 7702 Bc AH819 Bc Bc AH259 b y y b b 9 2+ b y 33.

- KLF6 869 bp IHH HepG2 Hep3B HuH bp- 800 bp- 700 bp- 600 bp- SV1 715 bp SV2 743 bp SV3 745 bp IHH HepG2 Hep3B HuH Percentage of.

D Day 2Day 1Day 4Day 6 Day 1 Day 2 Day 4 Day 6 Biopsy Injury D0 D1 D2 D3 D4 D5 D6 Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS.

Control VEGF 165 b bevacizumab PC3 cells Saline VEGF 165 b A. B. C.D SalineVEGF 165 b Bevacizumab Vessels/mm -2 ** * Supplementary.

Condition MiaPaCa-2 Control Gem (100nm) AZD1775 (200nM) Gem + AZD1775 Panc-1 Control Gem (50nm) AZD1775 (200nM) Gem + AZD1775 Capan-1 Control Gem (50nm)

SA-β-Gal positivity (%) Days after 6 Gy of IR exposure 3 Morphology SA-  -Gal 015 Supplementary Fig. S1 A B.

Shimura Supplemental Figure 1

Supplementary Figure 1. (A) Expression of DSB repair proteins

Supplementary data Figure S1 PBMC 20ug PBMC 5ug PBMC 1.25ug PBMC 0.3ug

Supplementary Figure 1. Importance of first neighbours in breast cancer, hepatocellular carcinoma and non-small cell lung cancer in the SignaLink network.

Progesterone receptor

Supplemental Digital Content 4

Dosimetric and Economic Comparison of Interstitial High-Dose-Rate Brachytherapy to Stereotactic Body Radiation Therapy for Liver Lesions Brian A. Hrycushko,

Mouse OBK (Serial section)

Course 3 Parallel Lines In the figure, line n || line m. Find the measure of the angle . 7 All obtuse angles in the figure are congruent m7 = 144°

ANP GAPDH CTL CTL+MB DB DB+MB CTL CTL+MB DB DB+MB

Supplementary Figure 1 (log fold change relative to untreated control)

Yunguang Sun, PhD, Luigi Moretti, MD, Nicholas J

Supplemental Figures Supplemental Figure 1.

Supplemental Figure 1 A B C.

(a) (b) SUPPLEMENTARY FIGURE 1:

Nat. Rev. Urol. doi: /nrurol

Supplementary Table 1 Akt2 is required for NNK-induced lung tumorigenesis but not for urethane-induced lung tumorigenesis while Akt3 may act as a tumor.

Volume 147, Issue 4, Pages (April 2015)

Western blots Kleinjan et al., “Drug-tunable multi-dimensional Synthetic Gene Control using Inducible Degron-tagged dCas9 Effectors”. dCas9 dCas9 GFP Histone.

A Effect of GO on survival stratified by CD33 expression on CD34+ blasts B Effect of GO dose on survival stratified by CD33 expression on CD34+ blasts.

1A 1B Supplementary Figure 1. Parp HT29 C-Parp Gapdh LoVo

Suppl.Figure 1 Transfected HEK293 cells -130kDa -100KDa Blot: -V5

Moving back: The radiation dose received from lumbar spine quantitative fluoroscopy compared to lumbar spine radiographs with suggestions for dose reduction

Suppl. Figure 1 A B C D #### #### **** **** & && #### #### **** **** &

a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)

Supplementary Figure S2

FLAG β-actin p53 SET M.w. kDa D β-actin p53 G9a

Supplementary Figure 1 Non-migrating cells Migrating cells

Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression.

AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,

Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small.

Figure S1 Figure S2.

8 slides for 4 panels (A-D)

BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non- small Cell Lung Carcinoma In Vitro Wenyan Li, MD, PhD, Bo Li, MD,

Relative protein levels

Supplemental Figure 1A Pt Pt Pre-treatment

* * Supplementary figure S4 A B C D

Supplementary figure S2

Supplementary Figure S1

Supplementary Figure 1 HCT116 MOLT4

Supplementary Figure 1. A

HeLa COS-7 Supplementary Figure S1 Coelho et al (2014) MM pSPL3 MM

Supplementary Figure S1

Supplementary Figure S4

Chemotherapeutic Drug Combination Index Description

20S proteasome activities

A B C D Supplementary Figure S1 UMSCC1 Plateau: 24 hr Pre-Treatment

Supplementary Figure S1

C A B * * * * HCC1954 HCC1569 Supplementary-Figure S5 Tumor cells sc.

Journal of the American College of Surgeons

* * * ** ** ** ** ** ** Fig. 1..

A B D C E F Supplementary Figure S4. Epping et al. IP: flag input IgG

The Chemical Biology of Human Vitamins

Supplement Figure 1 Untreated Thermal IMDP CPLL Untreated Thermal IMDP

Supplementary Figure 1 Hehlgans et al. HCT-15 SW48 SW480 SW620

--- 6-months’ therapy months’ therapy Supplementary Figure 1.

Michael Yan, Weidong Kong, Andrew Kerr, Michael Brundage

Presentation transcript:

Supplementary Figure S1 a VEGF 【H460】【HCC2429】 0Gy 42kDa 42kDa 1 1.1 1 1 8Gy 42kDa 42kDa 1 1.4 1 1.5 β-actin 45kDa 45kDa 0 20s 1 2 4 　 6 24 (h) 0 20s 1 2 4 　 6 24 (h) b Hes1 【H460】【HCC2429】 0Gy 8Gy β-actin 0 20s 1 2 4 　 6 24 (h) 0 20s 1 2 4 　 6 24 (h) c Hey 1 【H460】【HCC2429】 (fold) (fold) Radiation dose (Gy) Radiation dose (Gy) (n=3)